Showing results (201-210 of 239) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but AlsoJohn M S Bartlett, Christopher C McConkey, Alison F Munro, et al.
JMIR Research Protocols|October 12, 2022
Predicting Effective Adaptation to Breast Cancer to Help Women BOUNCE Back: Protocol for a Multicenter Clinical Pilot StudyGreta Pettini, Virginia Sanchini, Ruth Pat-Horenczyk, et al.
Nature Medicine|January 21, 2025
Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2- breast cancer: a randomized phase 3 trialFatima Cardoso, Joyce O'Shaughnessy, Zhenzhen Liu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2024
EUSOMA quality indicators for non-metastatic breast cancer: An updateIsabel T Rubio, Lorenza Marotti, Laura Biganzoli, et al.
Breast (Edinburgh, Scotland)|March 29, 2020
The requirements of a specialist breast centreLaura Biganzoli, Fatima Cardoso, Marc Beishon, et al.
Eclinicalmedicine|April 9, 2025
Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation studyLuigi Lim, Abigirl Machingura, Mekdes Taye, et al.
ESMO Open|February 22, 2018
Global cancer control: responding to the growing burden, rising costs and inequalities in accessGerald W Prager, Sofia Braga, Branislav Bystricky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Multifactorial approach to predicting resistance to anthracyclinesChristine Desmedt, Angelo Di Leo, Evandro de Azambuja, et al.
Translational Vision Science & Technology|January 18, 2019
Proceedings of the Association for Research in Vision and Ophthalmology and Champalimaud Foundation Ocular Oncogenesis and Oncology ConferenceJustine R Smith, Jacob Pe'er, Rubens N Belfort, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical TrialYen-Shen Lu, Seock-Ah Im, Marco Colleoni, et al.
Pageof 24